Replies to post #6401 on Synaptogenix Inc (SNPX)

[runncoach]

Yeah i saw that. Another potential slowing of the rate of decline.

[Cyosol]

Up 15% now, which means investors have valued these results at about $10 billion (for a drug which only seems to slow the decline of some early AD patients rather than reverse any damage).

Now imagine if investors treat positive results from our trial the same.

A $10 billion market cap boost would make NTRP shares worth about $1279.

That's more than a 12,900% increase.